The necessity to treat DCs with LL-37 during their differentiation, pulsation and maturation to attain a significant enhancement of the DC-mediated expansion of CD8+ T cells indicates that this expansion could also be associated with the promotion of CD8+ T cells that are reactive to tumor cells expressing the pulsed antigen. This evidence concerns the gene CD8A and neoplasm.